Efficiency and safety of melatonin receptor agonist for treatment of nocturia

Hirofumi Obata, Ryosuke Takahashi, Masatoshi Eto, Takakazu Yunoki, Toshihisa Tomoda

Research output: Contribution to journalArticle

Abstract

Purpose: We examined the efficacy of ramelteon for patients with insomnia and nocturia. Methods: Thirteen patients above the age of 50 years who were experiencing both insomnia and two or more nocturnal voids were included in the study. Patients who had polyuria of over 3,000 ml and post residual urine of over 100 ml were excluded. The patients were treated with ramelteon 8 mg for twelve weeks and the degree of lower urinary tract symptoms and sleep disorder was evaluated using the International Prostate Symptom Score (IPSS) and the N-QOL score at pre-treatment, 4 weeks, 8 weeks, and 12 weeks. Results: The mean IPSS score improved significantly from 15.7 ± 1.4 at baseline to 12.8 ± 3.1 at twelve weeks. The subject scores for the number of nocturnal voids also decreased significantly from 3.4 ± 0.2 to 2.5 ± 0.3. N-QOL score also improved significantly from 58.3 ± 12.4 to 68.8 ± 14.1. Conclusions: Ramelteon reduces both nocturia and disturbed sleep in patients with insomnia and nocturia.

Original languageEnglish
Pages (from-to)493-498
Number of pages6
JournalNishinihon Journal of Urology
Volume78
Issue number10
Publication statusPublished - Oct 1 2016

Fingerprint

Melatonin Receptors
Nocturia
Safety
Sleep Initiation and Maintenance Disorders
Prostate
Therapeutics
Polyuria
Lower Urinary Tract Symptoms
Sleep
Urine
ramelteon

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Obata, H., Takahashi, R., Eto, M., Yunoki, T., & Tomoda, T. (2016). Efficiency and safety of melatonin receptor agonist for treatment of nocturia. Nishinihon Journal of Urology, 78(10), 493-498.

Efficiency and safety of melatonin receptor agonist for treatment of nocturia. / Obata, Hirofumi; Takahashi, Ryosuke; Eto, Masatoshi; Yunoki, Takakazu; Tomoda, Toshihisa.

In: Nishinihon Journal of Urology, Vol. 78, No. 10, 01.10.2016, p. 493-498.

Research output: Contribution to journalArticle

Obata, H, Takahashi, R, Eto, M, Yunoki, T & Tomoda, T 2016, 'Efficiency and safety of melatonin receptor agonist for treatment of nocturia', Nishinihon Journal of Urology, vol. 78, no. 10, pp. 493-498.
Obata, Hirofumi ; Takahashi, Ryosuke ; Eto, Masatoshi ; Yunoki, Takakazu ; Tomoda, Toshihisa. / Efficiency and safety of melatonin receptor agonist for treatment of nocturia. In: Nishinihon Journal of Urology. 2016 ; Vol. 78, No. 10. pp. 493-498.
@article{9338f49de72f4873a7fa06e22210af54,
title = "Efficiency and safety of melatonin receptor agonist for treatment of nocturia",
abstract = "Purpose: We examined the efficacy of ramelteon for patients with insomnia and nocturia. Methods: Thirteen patients above the age of 50 years who were experiencing both insomnia and two or more nocturnal voids were included in the study. Patients who had polyuria of over 3,000 ml and post residual urine of over 100 ml were excluded. The patients were treated with ramelteon 8 mg for twelve weeks and the degree of lower urinary tract symptoms and sleep disorder was evaluated using the International Prostate Symptom Score (IPSS) and the N-QOL score at pre-treatment, 4 weeks, 8 weeks, and 12 weeks. Results: The mean IPSS score improved significantly from 15.7 ± 1.4 at baseline to 12.8 ± 3.1 at twelve weeks. The subject scores for the number of nocturnal voids also decreased significantly from 3.4 ± 0.2 to 2.5 ± 0.3. N-QOL score also improved significantly from 58.3 ± 12.4 to 68.8 ± 14.1. Conclusions: Ramelteon reduces both nocturia and disturbed sleep in patients with insomnia and nocturia.",
author = "Hirofumi Obata and Ryosuke Takahashi and Masatoshi Eto and Takakazu Yunoki and Toshihisa Tomoda",
year = "2016",
month = "10",
day = "1",
language = "English",
volume = "78",
pages = "493--498",
journal = "Nishinihon Journal of Urology",
issn = "0029-0726",
publisher = "Kyushu University, Faculty of Science",
number = "10",

}

TY - JOUR

T1 - Efficiency and safety of melatonin receptor agonist for treatment of nocturia

AU - Obata, Hirofumi

AU - Takahashi, Ryosuke

AU - Eto, Masatoshi

AU - Yunoki, Takakazu

AU - Tomoda, Toshihisa

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Purpose: We examined the efficacy of ramelteon for patients with insomnia and nocturia. Methods: Thirteen patients above the age of 50 years who were experiencing both insomnia and two or more nocturnal voids were included in the study. Patients who had polyuria of over 3,000 ml and post residual urine of over 100 ml were excluded. The patients were treated with ramelteon 8 mg for twelve weeks and the degree of lower urinary tract symptoms and sleep disorder was evaluated using the International Prostate Symptom Score (IPSS) and the N-QOL score at pre-treatment, 4 weeks, 8 weeks, and 12 weeks. Results: The mean IPSS score improved significantly from 15.7 ± 1.4 at baseline to 12.8 ± 3.1 at twelve weeks. The subject scores for the number of nocturnal voids also decreased significantly from 3.4 ± 0.2 to 2.5 ± 0.3. N-QOL score also improved significantly from 58.3 ± 12.4 to 68.8 ± 14.1. Conclusions: Ramelteon reduces both nocturia and disturbed sleep in patients with insomnia and nocturia.

AB - Purpose: We examined the efficacy of ramelteon for patients with insomnia and nocturia. Methods: Thirteen patients above the age of 50 years who were experiencing both insomnia and two or more nocturnal voids were included in the study. Patients who had polyuria of over 3,000 ml and post residual urine of over 100 ml were excluded. The patients were treated with ramelteon 8 mg for twelve weeks and the degree of lower urinary tract symptoms and sleep disorder was evaluated using the International Prostate Symptom Score (IPSS) and the N-QOL score at pre-treatment, 4 weeks, 8 weeks, and 12 weeks. Results: The mean IPSS score improved significantly from 15.7 ± 1.4 at baseline to 12.8 ± 3.1 at twelve weeks. The subject scores for the number of nocturnal voids also decreased significantly from 3.4 ± 0.2 to 2.5 ± 0.3. N-QOL score also improved significantly from 58.3 ± 12.4 to 68.8 ± 14.1. Conclusions: Ramelteon reduces both nocturia and disturbed sleep in patients with insomnia and nocturia.

UR - http://www.scopus.com/inward/record.url?scp=84995482326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995482326&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84995482326

VL - 78

SP - 493

EP - 498

JO - Nishinihon Journal of Urology

JF - Nishinihon Journal of Urology

SN - 0029-0726

IS - 10

ER -